Intuitive Surgical (NASDAQ:ISRG) Stock: Insider Fredrik Widman Sells 4,047 Shares

Posted by Brian Himes on Oct 26th, 2026

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) VP Fredrik Widman sold 4,047 shares of the firm’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the sale, the vice president directly owned 1,026 shares in the company, valued at approximately $464,993.46. The trade was a 79.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Fredrik Widman also recently made the following trade(s):

On Tuesday, September 15th, Fredrik Widman sold 1,089 shares of Intuitive Surgical stock. The stock was sold at an average price of $374.44, for a total transaction of $407,765.16.

Intuitive Surgical Trading Down 0.1%

NASDAQ:ISRG traded down $0.66 during midday trading on Monday, hitting $451.63. 2,916,696 shares of the company were exchanged, compared to its average volume of 2,433,892. The company has a fifty day simple moving average of $395.50 and a 200 day simple moving average of $408.83. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a market capitalization of $156.55 billion, a PE ratio of 54.61, a price-to-earnings-growth ratio of 3.12 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the firm posted $2.40 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Analysts and market commentators continue to view Intuitive Surgical as a strong growth company, citing durable demand for robotic-assisted surgery and potential for the stock to outperform the broader market. Intuitive Surgical Is an Incredible Growth Stock: 3 Reasons Why
Positive Sentiment: Higher earnings estimates are providing a near-term bullish catalyst. The revisions suggest analysts are becoming more optimistic about ISRG’s financial outlook, potentially supporting further gains. Earnings Estimates Moving Higher for Intuitive Surgical
Neutral Sentiment: ISRG is receiving elevated investor attention across financial websites, but the “trending stock” coverage is primarily informational rather than a new business or earnings announcement. Intuitive Surgical Is a Trending Stock: Facts to Know Before Betting on It
Neutral Sentiment: Commentary is also addressing whether Intuitive Surgical’s premium valuation is justified. This may keep investors selective even as the company’s long-term growth story remains intact. If Intuitive Surgical Stock Looks Expensive, You Need To Read This
Negative Sentiment: Director Gary Guthart sold 20,095 shares for approximately $9.1 million, reducing his direct ownership by 1.64%. Because the sale was made under a pre-arranged Rule 10b5-1 plan, it may not reflect a change in the company’s outlook, but insider selling can still weigh on sentiment. SEC Insider Transaction Filing

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. 3Chopt Investment Partners LLC grew its position in shares of Intuitive Surgical by 5.2% in the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock valued at $213,000 after purchasing an additional 23 shares during the period. Beaumont Financial Advisors LLC increased its stake in Intuitive Surgical by 3.8% in the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 23 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its stake in Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after purchasing an additional 25 shares during the last quarter. Blue Fin Capital Inc. lifted its position in Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after buying an additional 25 shares during the period. Finally, Red Spruce Capital LLC lifted its position in Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. Raymond James Financial restated an “outperform” rating and set a $480.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday. Finally, Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Check Out Our Latest Research Report on ISRG

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.